SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Sales for the quarter ended December 2024 of Rs. 0.34 million declined by -75.00% from Rs. 1.36 millions.The Net Loss for the quarter ended December 2024 is Rs. -1.07 millions as compared to Net Loss of Rs. -27.92 millions of corresponding quarter ended December 2023 Operating profit Margin for the quarter ended December 2024 improved to -1.33% as compared to -26.03% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 0.34 1.36 -75.00 2.98 19.75 -84.91 22.85 60.62 -62.31
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -1.33 -26.03 -94.89 -6.83 -33.11 -79.37 -63.64 5.63 -1230.37
Interest -0.15 1.41 -110.64 0.02 4.05 -99.51 4.82 3.96 21.72
PBDT -0.99 -27.45 -96.39 -6.66 -37.17 -82.08 -68.47 1.40 -4990.71
Depreciation 0.02 0.63 -96.83 0.12 1.81 -93.37 2.28 2.50 -8.80
PBT -1.01 -28.08 -96.40 -6.78 -38.98 -82.61 -70.75 -1.10 6331.82
TAX 0.06 -0.16 -137.50 0.07 -0.02 -450.00 9.66 -0.17 -5782.35
Deferred Tax 0.06 -0.16 -137.50 0.07 -0.02 -450.00 -3.28 -0.17 1829.41
PAT -1.07 -27.92 -96.17 -6.85 -38.96 -82.42 -80.41 -0.93 8546.24
Equity 81.31 81.31 0.00 81.31 81.31 0.00 81.31 81.31 0.00
PBIDTM(%) -391.18 -1913.97 -79.56 -229.19 -167.65 36.71 -278.51 9.29 -3098.82

Ortin Global Share Price

14.39 0.00 (0.00%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.45
Dr. Reddys Lab 1223.65
Cipla 1230.25
Zydus Lifesciences 929.45
Lupin 2335.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×